Back
RCM Technologies 10K Form
Buy
67
RCMT
RCM Technologies
Last Price:
22.87
Seasonality Move:
9.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | RCMT/RCM Technologies Quarterly |
2023-11-09 | 10Q | RCMT/RCM Technologies Quarterly |
2023-08-10 | 10Q | RCMT/RCM Technologies Quarterly |
2023-05-10 | 10Q | RCMT/RCM Technologies Quarterly |
2022-11-10 | 10Q | RCMT/RCM Technologies Quarterly |
2022-08-11 | 10Q | RCMT/RCM Technologies Quarterly |
Receive RCMT News And Ratings
See the #1 stock for the next 7 days that we like better than RCMT
RCMT Financial Statistics
Sales & Book Value
Annual Sales: | $263.24M |
---|---|
Cash Flow: | $-4.87M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.95 |
Price / Book: | 5.85 |
Profitability
EPS (TTM): | 1.95000 |
---|---|
Net Income (TTM): | $15.72M |
Gross Margin: | $76.7M |
Return on Equity: | 58.18% |
Return on Assets: | 13.41% |
RCM Technologies Earnings Forecast
Key RCM Technologies Financial Ratios
- The Gross Profit Margin over the past 37 years for RCMT is 29.14%.
- The Selling, General & Administrative Expenses for RCMT have been equal to 19.82% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 8.31% of Operating Income.
- The Net Earning history of RCMT is 6.39% of Total Revenues.
- Per Share Earnings over the last 37 years have been positive in 20 years.
RCM Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | RCMT |
CUSIP: | 749360 |
Website: | rcmt.com |
Debt
Debt-to-Equity Ratio: | 1.01 |
---|---|
Current Ratio: | 1.63 |
Quick Ratio: | 1.53 |
Price-to-Earnings
Trailing P/E Ratio: | 11.81 |
---|---|
Forward P/E Ratio: | 8.4 |
RCMT Technical Analysis vs Fundamental Analysis
Buy
67
RCM Technologies (RCMT)
is a Buy
Is RCM Technologies a Buy or a Sell?
-
RCM Technologies stock is rated a Buy
The current RCM Technologies [RCMT] share price is $23.15. The Score for RCMT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.